Icotinib Is an Active Treatment of Non-Small-Cell Lung Cancer: A Retrospective Study

BACKGROUND: Icotinib hydrochloride is a novel epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) with preclinical and clinical activity in non-small cell lung cancer (NSCLC). This retrospective analysis was performed to assess the efficacy of icotinib on patients with non-small-...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Xiaofeng, Zhu, Quan, Liu, Yiqian, Liu, Ping, Yin, Yongmei, Guo, Renhua, Lu, Kaihua, Gu, Yanhong, Liu, Lianke, Wang, Jinghua, Wang, Zhaoxia, Røe, Oluf Dimitri, Shu, Yongqian, Zhu, Lingjun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4023939/
https://www.ncbi.nlm.nih.gov/pubmed/24836053
http://dx.doi.org/10.1371/journal.pone.0095897

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4023939/
https://www.ncbi.nlm.nih.gov/pubmed/24836053
http://dx.doi.org/10.1371/journal.pone.0095897

Ejemplares similares